Gainers & Losers
Fri Mar 13 2026 09:55:44- Hindustan Unilever share price
- ₹2,163.301.30%
- Bharti Airtel share price
- ₹1,806.700.33%
Active Stocks
Fri Mar 13 2026 10:25:25- Yes Bank share price
- ₹18.81-2.59%
- Suzlon Energy share price
- ₹41.40-2.50%
- Tata Motors Passenger Vehi...
- ₹314.30-3.13%
- Eternal share price
- ₹216.00-2.37%
- Adani Power share price
- ₹146.70-1.61%
Concord Biotech Profit & Loss Annual
1,175.00 +0.90 (0.08%)Updated : 13 Mar 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 745.17 | 638.90 | 562.07 | 489.33 |
| Other Net | 9.60 | 10.05 | 14.51 | 6.69 |
| Diluted Weighted Average Shares | 10.46 | 10.46 | 10.46 | 10.46 |
| Gain( Loss)on Saleof Assets | -0.22 | 0.01 | -0.09 | -0.03 |
| Depreciation/ Amortization | 54.37 | 53.59 | 54.03 | 50.05 |
| Operating Income | 454.92 | 378.04 | 291.10 | 223.60 |
| Net Income | 371.64 | 308.10 | 240.09 | 174.93 |
| Income Availableto Com Excl Extra Ord | 371.64 | 308.10 | 240.09 | 174.93 |
| Other Operating Expenses Total | 9.08 | 7.94 | 4.97 | 4.50 |
| Net Income Before Taxes | 494.55 | 412.56 | 322.01 | 237.52 |
| Net Income After Taxes | 371.64 | 308.10 | 240.09 | 174.93 |
| Income Availableto Com Incl Extra Ord | 371.64 | 308.10 | 240.09 | 174.93 |
| Costof Revenue Total | 417.74 | 334.17 | 277.86 | 235.66 |
| Gross Profit | 782.34 | 682.77 | 575.31 | 477.28 |
| Interest Inc( Exp) Net- Non- Op Total | 30.26 | 24.46 | 16.50 | 7.25 |
| Diluted Net Income | 371.64 | 308.10 | 240.09 | 174.93 |
| DPS- Common Stock Primary Issue | 10.70 | 8.75 | - | - |
| Provisionfor Income Taxes | 122.91 | 104.46 | 81.93 | 62.59 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 371.64 | 308.10 | 240.09 | 174.93 |
| Total Revenue | 1,200.09 | 1,016.94 | 853.17 | 712.93 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,200.09 | 1,016.94 | 853.17 | 712.93 |
| Selling/ General/ Admin Expenses Total | 263.98 | 243.19 | 225.17 | 199.13 |
| Diluted Normalized EPS | 35.54 | 29.45 | 22.96 | 16.72 |
| Diluted EPS Excluding Extra Ord Items | 35.52 | 29.45 | 22.95 | 16.72 |
| Unusual Expense( Income) | - | 0.00 | 0.03 | - |
*All figures in crores except per share values
Concord Biotech Quick Links
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Key Metrics Concord Biotech Shareholdings Concord Biotech Balance Sheet Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,184.40+48.95(2.29%)
3,568.35+36.20(1.02%)
1,814.30+13.50(0.75%)
3,575.85-145.10 (-3.90%)
186.35-7.10 (-3.67%)